Combined, the European thermal ablation devices market-including sales derived from generators and energy-based catheters, electrodes/probes, disposables, procedure kits, and accessories used in the treatment of BPH, cancer/tumors, menorrhagia, and chronic venous insufficiency/varicose veins in the countries of France, Germany, Italy, Spain, and the United Kingdom-totaled more than an estimated $250 million. Despite ongoing European economic instability and severe budget constraints, each market segment profiled in this report is expected to increase at conservative yet positive compound annual growth rates over the next five years-ranging from approximately 2.6%-3.3%-due to growing demand, cost-efficiency and efficacy, the gradual adoption of improved, next-generation technologies, and an aging European population susceptible to various diseases/conditions.
This dynamic report from Medtech Insight includes analyses of leading products, markets, competitors, and emerging medical device technologies and opportunities. Covered products in this report include selected specialized energy-based generator systems, medical devices/instruments/accessories for the following minimally invasive or nonsurgical ablation treatment areas: BPH, cancer, chronic venous insufficiency/varicose veins, menorrhagia, as well as selected aesthetic areas, including skin rejuvenation/skin tightening and body sculpting/cellulite/targeted fat reduction. Other applications discussed include treatment of spinal denervation, stress urinary incontinence, and uterine fibroids.
EXECUTIVE SUMMARY i. Overview of Thermal Ablation ii. European Market for Thermal Ablation Devices iii. Methodology Exhibit ES-1: Thermal Effects on Tissue Exhibit ES-2: European Thermal Ablation Devices for Medically Necessary Care, Combined Market Forecast, 2011-2016 Exhibit ES-3: European Thermal Ablation Devices for Medically Necessary Care, Market Forecast, by Treatment Segment, 2011-2016 1. SELECTED EUROPEAN HEALTHCARE MARKETS 1.1 The European Union 1.1.1 A Common Currency 188.8.131.52 The Sovereign Debt Crisis 1.1.2 Late Payments Directive 1.1.3 Regulatory Policies 1.1.4 Reimbursement 1.1.5 Healthcare Spending 1.2 Selected European National Healthcare Profiles 1.2.1 France 184.108.40.206 Healthcare Organization and Reform 220.127.116.11 Hospital Services 18.104.22.168 Medical Services/Supplies Reimbursement 1.2.2 Germany 22.214.171.124 Healthcare Organization and Reform 126.96.36.199 Hospital Services 188.8.131.52 Medical Services/Supplies Reimbursement 1.2.3 Italy 184.108.40.206 Healthcare Organization and Reform 220.127.116.11 Hospital Services 18.104.22.168 Medical Services/Supplies Reimbursement 1.2.4 Spain 22.214.171.124 Healthcare Organization and Reform 126.96.36.199 Hospital Services 188.8.131.52 Medical Services/Supplies Reimbursement 1.2.5 United Kingdom 184.108.40.206 Healthcare Organization and Reform 220.127.116.11 Hospital Services 18.104.22.168 Medical Services/Supplies Reimbursement Exhibit 1-1: European Union, Medical Device Risk Classification System Exhibit 1-2: European Union Population Statistics Comparison for the Years 2000, 2010, and 2020 Exhibit 1-3: France, Selected National Healthcare Statistics Exhibit 1-4: Germany, Selected National Healthcare Statistics Exhibit 1-5: Italy, Selected National Healthcare Statistics Exhibit 1-6: Spain, Selected National Healthcare Statistics Exhibit 1-7: United Kingdom, Selected National Healthcare Statistics 2. THERMAL ABLATION DEVICES OVERVIEW 2.1 Applications for Thermal Ablation 2.1.1 Aesthetics-Skin Rejuvenation and Tightening 22.214.171.124 Alma Lasers 126.96.36.199 Cutera 188.8.131.52 Cynosure 184.108.40.206 Palomar Medical Technologies 220.127.116.11 Solta Medical 18.104.22.168 Syneron Medical 2.1.2 Aesthetics-Body Sculpting, Fat Reduction, and the Reduction in the Appearance of Cellulite 22.214.171.124 Cutera 126.96.36.199 Cynosure 188.8.131.52 Osyris Medical/LSO Medical 184.108.40.206 Solta Medical 220.127.116.11 Syneron Medical 18.104.22.168 Zeltiq Aesthetics 2.1.3 Benign Prostatic Hyperplasia 22.214.171.124 Transurethral Microwave Thermotherapy 126.96.36.199.1 American Medical Systems/ Endo Health Solutions 188.8.131.52.2 Boston Scientific 184.108.40.206.3 ProstaLund Operations 220.127.116.11.4 Urologix 18.104.22.168 Transurethral Needle Ablation 22.214.171.124 Laser- and Other Energy-Based Therapies 126.96.36.199.1 Holmium Laser Ablation/ Enucleation of the Prostate 188.8.131.52.1.1 Lumenis 184.108.40.206.2 Photoselective Vaporization of the Prostate 220.127.116.11.2.1 American Medical Systems/Endo Health Solutions 2.1.4 Cancer/Tumor Ablation 18.104.22.168 Radiofrequency Ablation 22.214.171.124.1 AngioDynamics 126.96.36.199.2 Boston Scientific 188.8.131.52.3 Celsion 184.108.40.206.4 Covidien 220.127.116.11.5 Thermedical 18.104.22.168 Other Ablation Methods 22.214.171.124.1 Cryoablation 126.96.36.199.1.1 Sanarus Technologies 188.8.131.52.2 Microwave Ablation 184.108.40.206.2.1 Covidien 220.127.116.11.2.2 Microsulis Medical and AngioDynamics 18.104.22.168.3 High-Intensity Focused Ultrasound 22.214.171.124.3.1 EDAP TMS 126.96.36.199.3.2 InSightec/Elbit Imaging 2.1.5 Menorrhagia/Endometrial Ablation 188.8.131.52 Boston Scientific 184.108.40.206 CooperSurgical/The Cooper Companies 220.127.116.11 Ethicon/Johnson & Johnson 18.104.22.168 Hologic 2.1.6 Spinal Decompression and Denervation 22.214.171.124 ArthroCare 126.96.36.199 Relievant Medsystems 188.8.131.52 Smith & Nephew 2.1.7 Stress Urinary Incontinence 184.108.40.206 Novasys Medical 2.1.8 Varicose Vein Ablation 220.127.116.11 AngioDynamics 18.104.22.168 CermaVEIN 22.214.171.124 Covidien 2.1.9 Uterine Fibroids 126.96.36.199 InSightec/Elbit Imaging 188.8.131.52 Philips Healthcare/Royal Philips Electronics Exhibit 2-1: Thermal Effects on Tissue Exhibit 2-2: The Accent Radiofrequency Platform Exhibit 2-3: The Pixel CO2 Fractional Laser System and Technology Exhibit 2-4: The Thermage CPT System Exhibit 2-5: Sublative and Sublime Skin Rejuvenation Technologies Exhibit 2-6: The TruSculpt Body Sculpting System Exhibit 2-7: The Cellulaze Cellulite Laser Workstation Exhibit 2-8: The Smartlipo LaserBodySculpting Workstations Exhibit 2-9: The LipoControl GPS Laser Assisted Lipolysis System Exhibit 2-10: A Step-by-Step LipoSonix Procedure Exhibit 2-11: The VelaShape II System Exhibit 2-12: The UltraShape Contour I Body Sculpting System Exhibit 2-13: The CoolSculpting System and Step-by-Step Process Exhibit 2-14: Advantages and Disadvantages of Minimally Invasive Therapy for Benign Prostatic Hyperplasia Exhibit 2-15: The CoreTherm System Exhibit 2-16: Five-Year Clinical Comparison of Symptomatic Reduction in Benign Prostatic Hyperplasia Using the CoreTherm System andCompetitiveTreatments Exhibit 2-17: The CoolWave and Targis Systems Exhibit 2-18: The Cooled ThermCath Advance Catheter Exhibit 2-19: Cooled ThermoTherapy, Selected Five-Year Clinical Trial Results Exhibit 2-20: Comparison of Cooled ThermoTherapy with Drug Therapy, Selected Clinical Results Exhibit 2-21: The Prostiva Radiofrequency Therapy System Exhibit 2-22: Holmium Laser Ablation of the Prostate Using the VersaPulse PowerSuite Laser System Exhibit 2-23: Selected Advantages of Holmium Laser Ablation Using the VersaPulse PowerSuite Compared with Photoselective Vaporization Using the GreenLight PV Exhibit 2-24: The GreenLight High Performance System Exhibit 2-25: The GreenLight Xcelerated Performance System Exhibit 2-26: The MoXy Liquid Cooled Fiber Exhibit 2-27: The Model 1500X Electrosurgical Generator, and StarBurst Xli-Enhanced and Semi-Flex Electrodes Exhibit 2-28: The StarBurst SDE and MRI Electrodes Exhibit 2-29: The NanoKnife Low Energy Direct Current System and Electrode Probes Exhibit 2-30: The RF 3000 Generator and LeVeen Needle Electrode Exhibit 2-31: The Cool-tip RF Ablation System Exhibit 2-32: The Cool-tip RF Ablation System E Series Exhibit 2-33: The HALOFLEX System Exhibit 2-34: The SERF Ablation System Exhibit 2-35: The Visica 2 Treatment System and Step-by-Step Cryoablation Process Exhibit 2-36: The Evident MWA System Exhibit 2-37: The Acculis MTA System and Three-Step Procedure Exhibit 2-38: The Ablatherm Robotic HIFU System Exhibit 2-39: The ExAblate System Exhibit 2-40: Breast Cancer Treatment Using the ExAblate System Exhibit 2-41: The Three-Step Endometrial Ablation Process Using the Genesys Hydro ThermAblator System Exhibit 2-42: The Her Option Cryoablation System Exhibit 2-43: The Gynecare ThermaChoice III Uterine Balloon Therapy System and a Comparison of Selected Outcome Data with Competitive Thermal Ablation Systems Exhibit 2-44: The NovaSure System and Step-by-Step Endometrial Ablation Process Exhibit 2-45: Selected Features of the Next-Generation NovaSure System Exhibit 2-46: Nucleoplasty Using Coblation Technology Exhibit 2-47: Intradiscal Electrothermal Therapy and Targeted Disc Decompression Exhibit 2-48: Renessa Treatment for Stress Urinary Incontinence Exhibit 2-49: The VenaCure EVLT System Exhibit 2-50: The SVS System for the Treatment of Varicose Veins Exhibit 2-51: The Venefit Targeted Endovenous Therapy System Exhibit 2-52: Endovenous Ablation Using the Venefit System Exhibit 2-53: Uterine Fibroid Treatment Using the ExAblate System Exhibit 2-54: Sonalleve Therapy 3. EUROPEAN THERMAL ABLATION DEVICES MARKET 3.1 Procedure Volumes 3.2 Market Forecast 3.3 Competitive Analysis 3.3.1 Benign Prostatic Hyperplasia Ablation 3.3.2 Cancer/Tumor Ablation 3.3.3 Endometrial Ablation 3.3.4 Endovenous Ablation 3.4 Other Thermal Ablation Markets 3.4.1 Aesthetics 184.108.40.206 Body Sculpting/Fat Reduction 3.4.2 Spinal Disc Decompression and Denervation Exhibit 3-1: Europe, Thermal Ablation, Procedure Volumes Forecast, by Type, 2011-2016 Exhibit 3-2: European Thermal Ablation Devices for Medically Necessary Care, Combined Market Forecast, 2011-2016 Exhibit 3-3: European Thermal Ablation Devices for Medically Necessary Care, Market Forecast, by Treatment Segment, 2011-2016 Exhibit 3-4: 2011, European Thermal Ablation Devices Market for Medically Necessary Care, Share of Sales, by Segment Exhibit 3-5: 2016, European Thermal Ablation Devices Market for Medically Necessary Care, Share of Sales, by Segment Exhibit 3-6: 2011, Benign Prostatic Hyperplasia Laser Ablation Products Market, Share by Supplier Exhibit 3-7: 2011, Benign Prostatic Hyperplasia Microwave and Radiofrequency Ablation Products Market, Share by Supplier Exhibit 3-8: 2011, Tumor Ablation Products Market, Share by Supplier Exhibit 3-9: 2011, Endometrial Ablation Products Market, Share by Supplier Exhibit 3-10: 2011, Endovenous Ablation Products Market, Share by Supplier Exhibit 3-11: Leading Nonsurgical Aesthetic Device Companies,Global Revenues, 2010-2011 Exhibit 3-12: 2011, Global Nonsurgical Aesthetic Devices Market, Share by Supplier Exhibit 3-13: 2012, Selected Nonsurgical Body Sculpting/Fat Reduction Systems 4. COMPANY PROFILES 4.1 AngioDynamics, Inc. 4.2 Boston Scientific Corporation 4.3 Covidien PLC 4.4 Endo Health Solutions, Inc. 4.5 Hologic, Inc. 4.6 InSightec LTD/Elbit Imaging LTD 4.7 Johnson & Johnson 4.8 Microsulis Medical LTD 4.9 Solta Medical, Inc. 4.10 Syneron Medical LTD 4.11 Zeltiq Aesthetics, Inc. APPENDIX: COMPANY LISTING